|
1
|
de Candia TR, Lee SH, Yang J, Browning BL,
Gejman PV, Levinson DF, Mowry BJ, Hewitt JK, Goddard ME, O'Donovan
MC, et al: Additive genetic variation in schizophrenia risk is
shared by populations of African and European descent. Am J Hum
Genet. 93:463–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sánchez-Blázquez P, Rodríguez-Muñoz M and
Garzón J: The cannabinoid receptor 1 associates with NMDA receptors
to produce glutamatergic hypofunction: Implications in psychosis
and schizophrenia. Front Pharmacol. 4:1692014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakashiba T, Cushman JD, Pelkey KA,
Renaudineau S, Buhl DL, McHugh TJ, Barrera V Rodriguez, Chittajallu
R, Iwamoto KS, McBain CJ, et al: Young dentate granule cells
mediate pattern separation, whereas old granule cells facilitate
pattern completion. Cell. 149:188–201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tannenholz L, Jimenez JC and Kheirbek MA:
Local and regional heterogeneity underlying hippocampal modulation
of cognition and mood. Front Behav Neurosci. 8:1472014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gaspar PA, Bustamante ML, Silva H and
Aboitiz F: Molecular mechanisms underlying glutamatergic
dysfunction in schizophrenia: Therapeutic implications. J
Neurochem. 111:891–900. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Howes OD and Murray RM: Schizophrenia: An
integrated sociodevelopmental-cognitive model. Lancet.
383:1677–1687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Penzes P, Cahill ME, Jones KA, VanLeeuwen
JE and Woolfrey KM: Dendritic spine pathology in neuropsychiatric
disorders. Nat Neurosci. 14:285–293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ju P and Cui D: The involvement of
N-methyl-d-aspartate receptor (NMDAR) subunit NR1 in the
pathophysiology of schizophrenia. Acta Biochim Biophys Sin
(Shanghai). 48:209–219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghasemi M, Phillips C, Trillo L, De Miguel
Z, Das D and Salehi A: The role of NMDA receptors in the
pathophysiology and treatment of mood disorders. Neurosci Biobehav
Rev. 47:336–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Henson MA, Roberts AC, Pérez-Otaño I and
Philpot BD: Influence of the NR3A subunit on NMDA receptor
functions. Prog Neurobiol. 91:23–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hardingham GE and Bading H: Synaptic
versus extrasynaptic NMDA receptor signalling: Implications for
neurodegenerative disorders. Nat Rev Neurosci. 11:682–696. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lau CG and Zukin RS: NMDA receptor
trafficking in synaptic plasticity and neuropsychiatric disorders.
Nat Rev Neurosci. 8:413–426. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Volianskis A, France G, Jensen MS,
Bortolotto ZA, Jane DE and Collingridge GL: Long-term potentiation
and the role of N-methyl-D-aspartate receptors. Brain Res.
1621:5–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bliss TV, Collingridge GL and Morris RG:
Synaptic plasticity in health and disease: Introduction and
overview. Philos Trans R Soc Lond B Biol Sci. 369:201301292013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soriano FX, Papadia S, Hofmann F,
Hardingham NR, Bading H and Hardingham GE: Preconditioning doses of
NMDA promote neuroprotection by enhancing neuronal excitability. J
Neurosci. 26:4509–4518. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones KS, Corbin JG and Huntsman MM:
Neonatal NMDA receptor blockade disrupts spike timing and
glutamatergic synapses in fast spiking interneurons in a NMDA
receptor hypofunction model of schizophrenia. PLoS One.
9:e1093032014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ahmad AS, Saleem S, Ahmad M and Doré S:
Prostaglandin EP1 receptor contributes to excitotoxicity and focal
ischemic brain damage. Toxicol Sci. 89:265–270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zapatero-Solana E, García-Giménez JL,
Guerrero-Aspizua S, García M, Toll A, Baselga E, Durán-Moreno M,
Markovic J, García-Verdugo JM, Conti CJ, et al: Oxidative stress
and mitochondrial dysfunction in Kindler syndrome. Orphanet J Rare
Dis. 9:2112014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiao Y, Liu C, Cui FM, Xu JY, Tong J, Qi
XF, Wang LL and Zhu W: Long intergenic non-coding RNA induced by
X-ray irradiation regulates DNA damage response signaling in the
human bronchial epithelial BEAS-2B cell line. Oncol Lett.
9:169–176. 2015.PubMed/NCBI
|
|
20
|
Zhang Z, Zhao C, Liu B, Liang D, Qin X, Li
X, Zhang R, Li C, Wang H, Sun D and Cao F: Inositol pyrophosphates
mediate the effects of aging on bone marrow mesenchymal stem cells
by inhibiting Akt signaling. Stem Cell Res Ther. 5:332014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pervaiz N and Hoffman-Goetz L: Immune cell
inflammatory cytokine responses differ between central and systemic
compartments in response to acute exercise in mice. Exerc Immunol
Rev. 18:142–157. 2012.PubMed/NCBI
|
|
22
|
Whiteford HA, Degenhardt L, Rehm J, Baxter
AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD,
Johns N, et al: Global burden of disease attributable to mental and
substance use disorders: Findings from the global burden of disease
study 2010. Lancet. 382:1575–1586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu J, Qi D, Xing M, Li R, Jiang K, Peng Y
and Cui D: MK-801 induces schizophrenic behaviors through
downregulating Wnt signaling pathways in male mice. Brain Res.
1385:281–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim TW, Kang HS, Park JK, Lee SJ, Baek SB
and Kim CJ: Voluntary wheel running ameliorates symptoms of
MK-801-induced schizophrenia in mice. Mol Med Rep. 10:2924–2930.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Knott AB and Bossy-Wetzel E: Nitric oxide
in health and disease of the nervous system. Antioxid Redox Signal.
11:541–554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mandillo S, Rinaldi A, Oliverio A and Mele
A: Repeated administration of phencyclidine, amphetamine and MK-801
selectively impairs spatial learning in mice: A possible model of
psychotomimetic drug-induced cognitive deficits. Behav Pharmacol.
14:533–544. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mohn AR, Gainetdinov RR, Caron MG and
Koller BH: Mice with reduced NMDA receptor expression display
behaviors related to schizophrenia. Cell. 98:427–436. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rujescu D, Bender A, Keck M, Hartmann AM,
Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Möller HJ and
Grunze H: A pharmacological model for psychosis based on
N-methyl-D-aspartate receptor hypofunction: Molecular, cellular,
functional and behavioral abnormalities. Biol Psychiatry.
59:721–729. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Watanabe Y, Müller MK, von Engelhardt J,
Sprengel R, Seeburg PH and Monyer H: Age-dependent degeneration of
mature dentate gyrus granule cells following NMDA receptor
ablation. Front Mol Neurosci. 8:872016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anastasio NC, Xia Y, O'Connor ZR and
Johnson KM: Differential role of N-methyl-D-aspartate receptor
subunits 2A and 2B in mediating phencyclidine-induced perinatal
neuronal apoptosis and behavioral deficits. Neuroscience.
163:1181–1191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kocsis B: Differential role of NR2A and
NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced
aberrant cortical gamma oscillations. Biol Psychiatry. 71:987–995.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inta D, Vogt MA, Luoni A, Filipović D,
Lima-Ojeda JM, Pfeiffer N, Gasparini F, Riva MA and Gass P:
Significant increase in anxiety during aging in mGlu5 receptor
knockout mice. Behav Brain Res. 241:27–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kristiansen LV, Huerta I, Beneyto M and
Meador-Woodruff JH: NMDA receptors and schizophrenia. Curr Opin
Pharmacol. 7:48–55. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Toro C and Deakin JF: NMDA receptor
subunit NRI and postsynaptic protein PSD-95 in hippocampus and
orbitofrontal cortex in schizophrenia and mood disorder. Schizophr
Res. 80:323–330. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park JK, Lee SJ and Kim TW: Treadmill
exercise enhances NMDA receptor expression in schizophrenia mice. J
Exerc Rehabil. 10:15–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Law AJ and Deakin JF: Asymmetrical
reductions of hippocampal NMDAR1 glutamate receptor mRNA in the
psychoses. Neuroreport. 12:2971–2974. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao XM, Sakai K, Roberts RC, Conley RR,
Dean B and Tamminga CA: Ionotropic glutamate receptors and
expression of N-methyl-D-aspartate receptor subunits in subregions
of human hippocampus: Effects of schizophrenia. Am J Psychiatry.
157:1141–1149. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ibrahim HM, Hogg AJ Jr, Healy DJ,
Haroutunian V, Davis KL and Meador-Woodruff JH: Ionotropic
glutamate receptor binding and subunit mRNA expression in thalamic
nuclei in schizophrenia. Am J Psychiatry. 157:1811–1823. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gono T, Kawaguchi Y, Kaneko H, Nishimura
K, Hanaoka M, Kataoka S, Okamoto Y, Katsumata Y and Yamanaka H:
Anti-NR2A antibody as a predictor for neuropsychiatric systemic
lupus erythematosus. Rheumatology (Oxford). 50:1578–1585. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Faust TW, Chang EH, Kowal C, Berlin R,
Gazaryan IG, Bertini E, Zhang J, Sanchez-Guerrero J, Fragoso-Loyo
HE, Volpe BT, et al: Neurotoxic lupus autoantibodies alter brain
function through two distinct mechanisms. Proc Natl Acad Sci USA.
107:pp. 18569–18574. 2010; View Article : Google Scholar : PubMed/NCBI
|
